FDA grapples with oversight of fecal transplants


Save Story
Leer en español

Estimated read time: 1-2 minutes

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

WASHINGTON (AP) — It's a low-cost treatment for a life-threatening infection. And it could cure up to 90 percent of patients with minimal side-effects -- often in a few days.

It's not a miracle drug. In fact, the treatment is profoundly simple, though somewhat icky: Take the stool of healthy patients to cure those with hard-to-treat intestinal infections.

A small but growing number of doctors have started using the so-called fecal transplants to treat a condition known as C-diff. It's a bacterial infection that causes nausea, cramping and diarrhea. The germ affects a half million Americans annually, killing about 15,000 of them.

But fecal transplants pose a challenge to the Food and Drug Administration. The treatment doesn't exactly fit into the agency's regulatory framework. It's decided to regulate the treatment as an experimental drug. The regulators have shown some flexibility in their approach, but some critics say the mere presence of government oversight is discouraging many doctors from offering transplants.

That has led some patients to seek out questionable "do-it-yourself" websites, forums and videos.

%@AP Links

APPHOTO MASR502: In this Thursday, June 19, 2014 photo, technical assistant Eliska Didyk, wearing protective gloves, displays a bottle containing human fecal matter solution, frozen to minus 80 degrees celsius, in an OpenBiome laboratory, in Medford, Mass. With many patients no longer responding to potent antibiotics, stool has emerged as a surprisingly effective treatment for hard-to-treat gut infections. (AP Photo/Steven Senne) (19 Jun 2014)

<<APPHOTO MASR502 (06/19/14)££

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Most recent U.S. stories

Related topics

U.S.
The Associated Press
    KSL.com Beyond Series

    KSL Weather Forecast

    KSL Weather Forecast
    Play button